Persistence, Discontinuation, and Switching Patterns of Newly Initiated TNF Inhibitor Therapy in Ankylosing Spondylitis Patients in the United States
Crossref DOI link: https://doi.org/10.1007/s40744-019-0148-4
Published Online: 2019-03-05
Published Print: 2019-06
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Hunter, Theresa
Schroeder, Krista
Sandoval, David
Deodhar, Atul
Funding for this research was provided by:
Eli Lilly and Company
Text and Data Mining valid from 2019-03-05
Version of Record valid from 2019-03-05
Article History
Received: 2 January 2019
First Online: 5 March 2019